Uncategorized
Meiji Seika Pharma to Launch Two Products from Santen Pharmaceutical Co., Ltd. in Indonesia
JAKARTA, Indonesia--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. “Meiji” has announced that it launched the following two products from Santen Pharmaceutical Co., Ltd. “Santen” in Indonesia, based on a working business agreement that Meiji entered in November of 2018 with Santen. Dry-eye treatment DIQUAS ophthalmic solution 3% (Diquafosol Sodium) Glaucoma and ocular hypertension treatment TAFLOTAN ophthalmic solution 0.0015% (Tafluprost) Based on the working business agreement with Santen, the